Home » Analyst Articles – Company Sum

State Street (STT) – Research Analysts’ Weekly Ratings Changes

State Street (NYSE: STT) received a number of ratings updates from brokerages and research firms in the last week: State Street had its “neutral” rating reaffirmed by analysts at JPMorgan Chase. They now have a $59.00 price target on the stock, up previously from $50.50. They wrote, “We maintain our Neutral rating on State Street relative to its trust bank peers due to its relatively... 

Weekly Research Analysts’ Ratings Changes for Celgene (CELG)

A number of stock research firms have changed their ratings and price targets for Celgene (NASDAQ: CELG) during the last seven days: Celgene had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $130.00 price target on the stock. Celgene had its “outperform” rating reaffirmed by analysts at RBC Capital. They now have a $115.00 price... 

Weekly Research Analysts’ Ratings Changes for Pengrowth Energy Corp (PGH)

A number of stock research firms have changed their ratings and price targets for Pengrowth Energy Corp (NYSE: PGH) during the last seven days: Pengrowth Energy Corp had its price target lowered by analysts at Canaccord Genuity from $8.00 to $7.50. Pengrowth Energy Corp had its price target lowered by analysts at Scotiabank from $8.75 to $8.00. Pengrowth Energy Corp had its “sector outperform”... 

Recent Research Analysts’ Ratings Updates for Jazz Pharmaceuticals (JAZZ)

A number of stock research firms have changed their ratings and price targets for Jazz Pharmaceuticals (NASDAQ: JAZZ) during the last seven days: Jazz Pharmaceuticals is now covered by analysts at Bank of America. They set a “buy” rating and a $74.00 price target on the stock. They wrote, “We initiated coverage of Jazz with a Buy rating and $74 PO, which is based on a sum-of-the-parts... 

Vitamin Shoppe (VSI) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Vitamin Shoppe (NYSE: VSI) recently: Vitamin Shoppe had its price target lowered by analysts at Wedbush to $54.00. They wrote, “A reduction in 2013 guidance for new store openings to 50 from 57, due to co-tenants in certain development projects delaying signing leases, keeping builders from beginning work on the projects,... 

Analysts’ Weekly Ratings Changes for Dendreon (DNDN)

Dendreon (NASDAQ: DNDN) was the recipient of a ratings changes during the seven days: Dendreon had its “sell” rating reaffirmed by analysts at Brean Murray. They now have a $2.00 price target on the stock. Dendreon had its price target raised by analysts at Roth Capital from $5.00 to $6.30. They now have a “neutral” rating on the stock. Dendreon had its “neutral”... 

Weekly Research Analysts’ Ratings Changes for J.C. Penney Company (JCP)

A number of stock research firms have changed their ratings and price targets for J.C. Penney Company (NYSE: JCP) during the last seven days: J.C. Penney Company had its “sell” rating reaffirmed by analysts at UBS AG. They now have a $10.00 price target on the stock, down previously from $13.00. J.C. Penney Company had its price target lowered by analysts at Argus from $35.00 to $25.00.... 

Investment Analysts’ Recent Ratings Updates for Pinnacle West Capital (PNW)

Several investment firms have updated their stock ratings and price targets on shares of Pinnacle West Capital (NYSE: PNW) in the last week: Pinnacle West Capital had its price target raised by analysts at RBC Capital from $54.00 to $55.00. They now have a “sector perform” rating on the stock. Pinnacle West Capital had its “market perform” rating reaffirmed by analysts at... 
© 2010-2013 The Utah People's Post, Inc. · RSS. · Subscribe Subscribe